Written by
Mustafa Çelik
Mustafa Çelik Liv Hospital Content Team
Medically reviewed by

Related Doctors

Assoc. Prof. MD. Evrim Duman Liv Hospital Ulus Assoc. Prof. MD. Evrim Duman Radiation Oncology Asst. Prof. MD. Meltem Topalgökçeli Selam Liv Hospital Ulus Asst. Prof. MD. Meltem Topalgökçeli Selam Medical Oncology Prof. MD. Duygu Derin Liv Hospital Ulus Prof. MD. Duygu Derin Medical Oncology Prof. MD. Emre Merdan Fayda Liv Hospital Ulus Prof. MD. Emre Merdan Fayda Radiation Oncology Prof. MD. Meral Günaldı Liv Hospital Ulus Prof. MD. Meral Günaldı Medical Oncology Assoc. Prof. MD. Murat Ayhan Liv Hospital Vadistanbul Assoc. Prof. MD. Murat Ayhan Medical Oncology Prof. MD.  Itır Şirinoğlu Demiriz Liv Hospital Vadistanbul Prof. MD. Itır Şirinoğlu Demiriz Hematology Prof. MD. Tülin Tıraje Celkan Liv Hospital Vadistanbul Prof. MD. Tülin Tıraje Celkan Pediatric Hematology and Oncology Assoc. Prof. MD. Erkan Kayıkçıoğlu Liv Hospital Bahçeşehir Assoc. Prof. MD. Erkan Kayıkçıoğlu Medical Oncology Assoc. Prof. MD. Mine Dağgez Liv Hospital Bahçeşehir Assoc. Prof. MD. Mine Dağgez Gynecological Oncology Assoc. Prof. MD. Ozan Balakan Liv Hospital Bahçeşehir Assoc. Prof. MD. Ozan Balakan Medical Oncology MD. Taylan Bükülmez Liv Hospital Bahçeşehir MD. Taylan Bükülmez Radiation Oncology Op. MD. Alp Koray Kinter Liv Hospital Bahçeşehir Op. MD. Alp Koray Kinter Gynecological Oncology Prof. MD. Nuri Faruk Aykan Liv Hospital Bahçeşehir Prof. MD. Nuri Faruk Aykan Medical Oncology Spec. MD. Özlem Doğan Liv Hospital Bahçeşehir Spec. MD. Özlem Doğan Medical Oncology Assoc. Prof. MD. Emir Çelik Liv Hospital Topkapı Assoc. Prof. MD. Emir Çelik Medical Oncology Assoc. Prof. MD. Muhammed Mustafa Atcı Liv Hospital Topkapı Assoc. Prof. MD. Muhammed Mustafa Atcı Medical Oncology Prof. MD. İrfan Çiçin Liv Hospital Topkapı Prof. MD. İrfan Çiçin Medical Oncology Assoc. Prof. MD.  Ramazan Öcal Liv Hospital Ankara Assoc. Prof. MD. Ramazan Öcal Hematology Assoc. Prof. MD. Nazlı Topfedaisi Özkan Liv Hospital Ankara Assoc. Prof. MD. Nazlı Topfedaisi Özkan Gynecological Oncology Prof. MD. Fikret Arpacı Liv Hospital Ankara Prof. MD. Fikret Arpacı Medical Oncology Prof. MD. Gökhan Erdem Liv Hospital Ankara Prof. MD. Gökhan Erdem Medical Oncology Prof. MD. Meral Beksaç Liv Hospital Ankara Prof. MD. Meral Beksaç Hematology Prof. MD. Oral Nevruz Liv Hospital Ankara Prof. MD. Oral Nevruz Hematology Prof. MD. Saadettin Kılıçkap Liv Hospital Ankara Prof. MD. Saadettin Kılıçkap Medical Oncology Prof. MD. Sadık Muallaoğlu Liv Hospital Ankara Prof. MD. Sadık Muallaoğlu Medical Oncology Spec. MD. Ender Kalacı Liv Hospital Ankara Spec. MD. Ender Kalacı Medical Oncology Assoc. Prof. MD. Fadime Ersoy Dursun Liv Hospital Gaziantep Assoc. Prof. MD. Fadime Ersoy Dursun Hematology Prof. MD. Fatih Teker Liv Hospital Gaziantep Prof. MD. Fatih Teker Medical Oncology Spec. MD. ELXAN MEMMEDOV Liv Bona Dea Hospital Bakü Spec. MD. ELXAN MEMMEDOV Medical Oncology Spec. MD. Ceyda Aslan Spec. MD. Ceyda Aslan Hematology Spec. MD. Elkhan Mammadov Spec. MD. Elkhan Mammadov Medical Oncology Spec. MD. Elmir İsrafilov Spec. MD. Elmir İsrafilov Hematology Spec. MD. Minure Abışova Eliyeva Spec. MD. Minure Abışova Eliyeva Hematology Spec. MD. Natavan Azizova Spec. MD. Natavan Azizova Medical Oncology Prof. MD. Mehmet Hilmi Doğu Liv Hospital Ulus + Liv Hospital Bahçeşehir Prof. MD. Mehmet Hilmi Doğu Hematology
...
Views
Read Time
...
views
Read Time
Lung Cancer Symptoms: Best Choice Guide
Lung Cancer Symptoms: Best Choice Guide 5

We know how tough lung cancer is for people all over the world. It’s a big reason for cancer deaths in the U.S. It mainly comes in two types: Non-Small Cell Lung Cancer (NSCLC) and Small Cell Lung Cancer (SCLC). Are your lung cancer symptoms worsening? Discover the best life-saving treatments and how to choose the most effective path to recovery.

Spotting the symptoms of lung cancer early is key. We aim to give our patients the latest, most ethical treatments. We tailor our care to meet the needs of patients from around the globe.

We offer full support to make sure our patients get the top care. Knowing about the types of cancer helps us choose the right treatment for each person.

Key Takeaways

  • Understanding the main types of lung cancer is key for effective treatment.
  • Early detection greatly boosts survival chances.
  • Personalized care plans are vital for patients from abroad.
  • Advanced treatments are available for both NSCLC and SCLC.
  • Comprehensive support is at the heart of our patient care.

Understanding Lung Cancer: Types and Prevalence

Understanding Lung Cancer: Types and Prevalence
Lung Cancer Symptoms: Best Choice Guide 6

Lung cancer is a major cause of death from cancer. It is mainly split into two types: Non-Small Cell Lung Cancer (NSCLC) and Small Cell Lung Cancer (SCLC). Knowing about these types and how common they are is key for finding and treating the disease.

Non-Small Cell Lung Cancer vs. Small Cell Lung Cancer

NSCLC makes up about 85% of lung cancer cases, making it the most common. It grows and spreads slower than SCLC, which is more aggressive but less common, making up about 15% of cases. Knowing the difference between these types is important because it affects treatment choices and how well a patient might do.

For more detailed stats on lung cancer, we can look at recent updates from places like the American Cancer Society. These stats help us understand who gets lung cancer and why.

Epidemiology and Risk Factors

Lung cancer is a big health problem around the world. Its rates of occurrence and death vary by region. It’s the second most common cancer in both men and women, with some groups facing higher risks due to smoking, exposure to harmful substances, and genetics.

Type of Lung Cancer

Prevalence

Characteristics

Non-Small Cell Lung Cancer (NSCLC)

85%

Grows and spreads slowly

Small Cell Lung Cancer (SCLC)

15%

More aggressive, faster growth

It’s important to know the risk factors and how common different lung cancers are. This helps in creating better ways to prevent and treat lung cancer. By understanding the differences between NSCLC and SCLC, doctors can give treatments that fit each patient’s needs, leading to better results.

Recognizing Lung Cancer Symptoms: Early Detection Saves Lives

Recognizing Lung Cancer Symptoms: Early Detection Saves Lives
Lung Cancer Symptoms: Best Choice Guide 7

It’s important to know the symptoms of lung cancer early. This can greatly improve survival chances. Lung cancer often shows symptoms that can be confused with other illnesses. So, being aware is key for early diagnosis.

Common Warning Signs

Lung cancer symptoms vary based on the type and stage. Here are some common signs:

  • A persistent cough that does not go away or worsens over time
  • Chest pain that is often worse with deep breathing, coughing, or laughing
  • Hoarseness or changes in the voice
  • Unexplained weight loss
  • Coughing up blood or rust-colored sputum

These symptoms can be seen in both non-small cell lung cancer and small cell lung cancer. This includes squamous cell lung carcinoma.

When to Seek Medical Attention

If you or someone you know has these symptoms, get medical help. Early detection can lead to better treatment results. We suggest seeing a doctor if symptoms don’t go away or get worse.

A doctor will do a detailed check-up. This includes looking at your medical history and doing tests like imaging and biopsies. They aim to find out what’s causing your symptoms.

Diagnosis and Staging: The Critical First Steps

Diagnosis and Staging: The Critical First Steps
Lung Cancer Symptoms: Best Choice Guide 8

Knowing how far and what type of lung cancer you have is key for treatment. We use imaging tests and biopsies to find out. This helps us decide the best treatment plan.

Diagnostic Procedures and Tests

Diagnosing lung cancer starts with imaging tests like CT scans and PET-CT scans. These help us see the tumor and check if it has spread. The SEER Cancer Statistics Review shows these tests are vital for planning further steps.

Next, a biopsy confirms cancer and finds out the type, like adenocarcinoma lung. Knowing this helps us pick the right lung cancer treatment.

Understanding Cancer Staging and Its Impact on Treatment Selection

Cancer staging tells us how far the cancer has spread. The stage is key for choosing the best treatment for lung cancer. We use the TNM system, looking at tumor size, lymph node involvement, and metastasis.

Cancer Stage

Description

Typical Treatment Approach

Stage I

Cancer is localized, small in size

Surgery or Stereotactic Body Radiation Therapy (SBRT)

Stage II

Cancer is larger or has spread to nearby lymph nodes

Surgery followed by chemotherapy or radiation therapy

Stage III

Cancer has spread to lymph nodes or other structures in the chest

Combination of chemotherapy and radiation therapy

Stage IV

Cancer has spread to distant parts of the body

Systemic treatments such as chemotherapy, targeted therapy, or immunotherapy

Getting the cancer stage right is important. It affects the treatment choice. Early-stage cancer might get surgery or radiation. But more advanced cancer needs treatments like chemotherapy or immunotherapy.

Surgical Interventions for Lung Cancer

Surgery is a key part of treating lung cancer, giving hope to many. It’s often chosen when the cancer is in one place and can be taken out without harming the lung too much.

Types of Lung Cancer Surgery

There are different surgeries for lung cancer, each with its own use and benefits. The main types are:

  • Lobectomy: This is when the whole lobe of the lung with the tumor is removed. It’s the most common surgery for lung cancer that’s caught early.
  • Segmentectomy: This surgery takes out a smaller part of the lung. It’s good for people with cancer that’s just starting or who can’t handle a big surgery.
  • Pneumonectomy: This is when the whole lung is removed. It’s usually done when the tumor is big or in the middle of the lung.

The type of surgery depends on the tumor’s size, where it is, and the patient’s health.

Candidacy and Recovery Expectations

Not every lung cancer patient can have surgery. Doctors look at the cancer’s stage, the patient’s health, and how well the lungs work. People with early-stage non-small cell lung cancer usually qualify. How long it takes to recover varies, but it can be several weeks.

Advantages and Limitations of Surgical Approaches

Surgery can be a cure for early-stage lung cancer. It removes the tumor, helps with symptoms, and might increase survival chances. But, surgery also has risks like infection and bleeding. Some people might not be good candidates, and some might have the cancer come back.

Knowing these points helps patients make better choices about their treatment.

Radiation Therapy Approaches

Radiation therapy for lung cancer has grown a lot. It offers many choices for patients and doctors. It can be the main treatment or used with surgery or chemo, based on the cancer’s stage and type.

External Beam Radiation vs. Internal Radiation Methods

There are two main ways to use radiation therapy for lung cancer: external beam radiation therapy (EBRT) and brachytherapy. EBRT sends high-energy rays from outside the body to the tumor. Brachytherapy puts radioactive material inside or near the tumor.

EBRT is more common for lung cancer. It treats bigger areas and tumors. New techniques like IMRT and IGRT have made EBRT more precise and less harmful.

Therapy Type

Description

Application

External Beam Radiation Therapy (EBRT)

High-energy rays directed from outside the body to the tumor

Commonly used for larger tumors or more extensive disease

Brachytherapy (Internal Radiation)

Radioactive material placed directly inside or near the tumor

Used for localized tumors or in combination with EBRT

Stereotactic Body Radiation Therapy (SBRT) for Early-Stage Cancer

Stereotactic Body Radiation Therapy (SBRT) is a special EBRT. It gives precise, high doses to small, well-defined tumors. SBRT works best for early-stage non-small cell lung cancer that can’t be removed surgically or in patients who can’t have surgery.

SBRT is very precise, which means less harm to healthy tissue. This reduces side effects and improves life quality. The treatment is short, with just a few sessions, making it easy for patients.

Systemic Treatments: Comparing Effectiveness and Applications

Systemic treatments like chemotherapy, immunotherapy, and targeted therapies have changed how we fight lung cancer. These methods aim to attack cancer cells all over the body. They are key parts of lung cancer treatment plans.

Chemotherapy Protocols

Chemotherapy is a big help in treating lung cancer, mainly small cell lung cancer. It uses drugs to kill fast-growing cancer cells. But, it can also harm healthy cells, leading to side effects.

The right chemotherapy depends on the lung cancer’s stage and type, and the patient’s health. Drugs like cisplatin, carboplatin, and docetaxel are common. Mixing these drugs can make treatment more effective.

Immunotherapy Advances

Immunotherapy is a big step forward in lung cancer treatment. It uses the body’s immune system to fight cancer. Drugs like pembrolizumab and nivolumab work well on non-small cell lung cancer by blocking the PD-1/PD-L1 pathway.

Choosing the right patient for immunotherapy is important. It involves checking for specific biomarkers, like PD-L1. Immunotherapy can lead to long-lasting benefits and better survival rates for some patients. But, it can also cause immune-related side effects.

Targeted Therapies

Targeted therapies aim at specific genetic mutations that cause lung cancer to grow. For example, EGFR inhibitors like erlotinib help patients with EGFR mutations. ALK inhibitors, such as crizotinib, are for those with ALK rearrangements.

How well targeted therapies work depends on the presence of certain genetic markers. They can offer big benefits with fewer side effects than traditional chemotherapy. This makes them a good choice for patients with specific genetic changes.

Treatment Type

Key Characteristics

Patient Selection Criteria

Chemotherapy

Cytotoxic drugs targeting rapidly dividing cells

Stage and type of lung cancer, overall health

Immunotherapy

Harnesses immune system to fight cancer

PD-L1 expression, other specific biomarkers

Targeted Therapies

Targets specific genetic mutations

Presence of specific genetic markers (e.g., EGFR, ALK)

Personalized Treatment Selection: Which Approach is Best for Different Best for Different Patients

We think the best lung cancer treatment is one that fits the patient’s needs. This includes their health, preferences, and cancer type and stage. Choosing the right treatment depends on many factors, like the cancer’s stage and the patient’s health.

Stage-Based Treatment Recommendations

Lung cancer treatment changes with the cancer’s stage. For early-stage cancer, surgery or SBRT might be the best options. They could lead to a cure. For more advanced stages, treatments like chemotherapy, targeted therapy, or immunotherapy are often used. These help control the disease and improve life quality.

Considering Patient-Specific Factors

Each patient’s health and preferences are key in choosing treatment. We look at their overall health, any other health issues, and how they feel. For example, someone with serious health problems might not be a good candidate for surgery. Instead, they might get radiation therapy or systemic treatments.

Combination Therapy Approaches

Using more than one treatment at a time is becoming common in lung cancer care. This method aims to improve results. We might use surgery, radiation, and systemic treatments together. For example, chemotherapy or immunotherapy might be used before surgery to make the tumor smaller.

Survival Rates and Treatment Outcomes

Recent studies show a positive trend in lung cancer survival rates, thanks to early-stage diagnoses. As we advance in detection and treatment, the outlook for lung cancer patients is getting better.

Stage-Based Survival Statistics and Recent Improvements

Lung cancer survival rates depend a lot on when the cancer is found. The 5-year survival rate is 61% for those found early, compared to 6% for those found late. Early detection through screening has been key in improving these numbers.

Advances in treatment have also helped improve survival rates. Surgery, radiation, and systemic treatments have gotten better, leading to better patient outcomes. For example, stereotactic body radiation therapy (SBRT) has shown great results in treating early-stage lung cancer.

Quality of Life Considerations in Treatment Selection

Survival rates are important, but so is the quality of life during and after treatment. Treatment choices must weigh the benefits against the impact on quality of life. Some treatments may greatly improve survival but have big side effects.

As we move towards personalized treatments, it’s vital to consider each patient’s health, preferences, and lifestyle. Patient-centered care means tailoring treatment plans to meet each patient’s needs. This approach improves both survival and quality of life.

“The goal of lung cancer treatment is not only to extend survival but to ensure that the patient maintains the best possible quality of life.”

— Expert Oncologist

By focusing on both survival rates and quality of life, we can offer complete care for lung cancer patients.

Conclusion: Making Informed Decisions About Lung Cancer Treatment

To make good choices about lung cancer treatment, you need to know a lot about the disease. It’s important to spot lung cancer symptoms early. This helps doctors treat it better and faster.

We talked about different ways to treat lung cancer. These include surgery, radiation, and other treatments. What works best for each person is often a mix of these methods.

Our team is ready to help patients from around the world. We create treatment plans that fit each person’s needs. This way, we ensure they get the best care possible.

Knowing about lung cancer symptoms and treatments helps patients make smart choices. We’re here to guide and support you every step of the way.

FAQ

What are the main types of lung cancer?

Lung cancer is mainly divided into two types: Non-Small Cell Lung Cancer (NSCLC) and Small Cell Lung Cancer (SCLC). NSCLC is more common, making up about 85% of cases. SCLC, on the other hand, is more aggressive and is closely linked to smoking.

What are the common symptoms of lung cancer?

Symptoms of lung cancer include a persistent cough, chest pain, and coughing up blood. You might also experience shortness of breath, wheezing, and recurring respiratory infections. If you notice any of these symptoms, it’s important to see a doctor.

How is lung cancer diagnosed?

Doctors use imaging tests like CT scans and X-rays to diagnose lung cancer. They also perform biopsies and other tests. Accurate diagnosis is key to figuring out the type and stage of lung cancer. This information helps choose the right treatment.

What are the treatment options for lung cancer?

Treatments for lung cancer include surgery, radiation therapy, and chemotherapy. Immunotherapy and targeted therapies are also used. The treatment plan depends on the cancer’s type, stage, and genetic makeup, as well as the patient’s health.

What is the difference between NSCLC and SCLC treatment approaches?

NSCLC treatment often involves surgery, radiation, and targeted therapies. SCLC, being more aggressive, is usually treated with chemotherapy and radiation. This is because SCLC spreads quickly.

How does cancer staging affect treatment outcomes?

Cancer staging is very important for treatment outcomes. Early-stage lung cancer is more likely to be treated successfully. Advanced-stage cancer may need more aggressive treatments.

What is Stereotactic Body Radiation Therapy (SBRT)?

SBRT is a precise radiation therapy that targets small areas of the body. It’s often used for early-stage lung cancer. It can be a good alternative to surgery for some patients.

What are the benefits of targeted therapies in lung cancer treatment?

Targeted therapies aim at specific genetic mutations in cancer cells. They are more effective and have fewer side effects than traditional chemotherapy. They work best for patients with specific genetic profiles.

How do patient-specific factors influence treatment selection?

Factors like overall health, age, and genetic makeup are important in choosing treatment. These factors help tailor the treatment plan to each patient’s needs.

What is the importance of quality of life considerations in lung cancer treatment?

Quality of life is a big part of lung cancer treatment. It affects physical, emotional, and social well-being. We focus on treatments that improve survival rates and quality of life, with fewer side effects.

What are the survival rates for lung cancer, and how have they improved?

Survival rates for lung cancer vary by stage and type. Advances in treatments like immunotherapy and targeted therapies have improved survival rates for many patients.

What is adenocarcinoma lung cancer, and how is it treated?

Adenocarcinoma is a type of NSCLC that starts in glandular cells. Treatment depends on the stage and genetic makeup. It may include surgery, radiation, targeted therapies, or a combination of these.

What is oat cell carcinoma, and how does it differ from other types of lung cancer?

Oat cell carcinoma is an old term for Small Cell Lung Cancer (SCLC). SCLC is very aggressive and requires intensive treatment. This usually includes chemotherapy and radiation therapy.

How does squamous cell lung carcinoma differ from other types of NSCLC?

Squamous cell lung carcinoma starts in squamous cells. It grows and spreads differently than other NSCLC types. Treatment depends on the stage and characteristics of the cancer.

References

National Center for Biotechnology Information. Evidence-Based Medical Insight. Retrieved from https://pubmed.ncbi.nlm.nih.gov/37227928/

i

Medical Disclaimer

The content on this page is for informational purposes only and is not a substitute for professional medical advice, diagnosis or treatment. Always consult a qualified healthcare provider regarding any medical conditions.

Book a Free Certified Online
Doctor Consultation

Clinics/branches
GDPR

We're Here to Help.
Get in Touch

Send us all your questions or requests, and our
expert team will assist you.

Our Doctors

Assoc. Prof. MD. Evrim Duman Radiation Oncology

Assoc. Prof. MD. Evrim Duman

Liv Hospital Ulus
Asst. Prof. MD. Meltem Topalgökçeli Selam Medical Oncology

Asst. Prof. MD. Meltem Topalgökçeli Selam

Liv Hospital Ulus
Prof. MD. Duygu Derin Medical Oncology

Prof. MD. Duygu Derin

Liv Hospital Ulus
Prof. MD. Emre Merdan Fayda Radiation Oncology

Prof. MD. Emre Merdan Fayda

Liv Hospital Ulus
Prof. MD. Mehmet Hilmi Doğu Hematology

Prof. MD. Mehmet Hilmi Doğu

Liv Hospital Ulus
Liv Hospital Bahçeşehir
Prof. MD. Meral Günaldı Medical Oncology

Prof. MD. Meral Günaldı

Liv Hospital Ulus
Assoc. Prof. MD. Murat Ayhan Medical Oncology

Assoc. Prof. MD. Murat Ayhan

Liv Hospital Vadistanbul
Prof. MD.  Itır Şirinoğlu Demiriz Hematology

Prof. MD. Itır Şirinoğlu Demiriz

Liv Hospital Vadistanbul
Prof. MD. Tülin Tıraje Celkan Pediatric Hematology and Oncology

Prof. MD. Tülin Tıraje Celkan

Liv Hospital Vadistanbul
Assoc. Prof. MD. Erkan Kayıkçıoğlu Medical Oncology

Assoc. Prof. MD. Erkan Kayıkçıoğlu

Liv Hospital Bahçeşehir
Assoc. Prof. MD. Mine Dağgez Gynecological Oncology

Assoc. Prof. MD. Mine Dağgez

Liv Hospital Bahçeşehir
Assoc. Prof. MD. Ozan Balakan Medical Oncology

Assoc. Prof. MD. Ozan Balakan

Liv Hospital Bahçeşehir
MD. Taylan Bükülmez Radiation Oncology

MD. Taylan Bükülmez

Liv Hospital Bahçeşehir
Op. MD. Alp Koray Kinter Gynecological Oncology

Op. MD. Alp Koray Kinter

Liv Hospital Bahçeşehir
Prof. MD. Nuri Faruk Aykan Medical Oncology

Prof. MD. Nuri Faruk Aykan

Liv Hospital Bahçeşehir
Spec. MD. Özlem Doğan Medical Oncology

Spec. MD. Özlem Doğan

Liv Hospital Bahçeşehir
Assoc. Prof. MD. Emir Çelik Medical Oncology

Assoc. Prof. MD. Emir Çelik

Liv Hospital Topkapı
Assoc. Prof. MD. Muhammed Mustafa Atcı Medical Oncology

Assoc. Prof. MD. Muhammed Mustafa Atcı

Liv Hospital Topkapı
Prof. MD. İrfan Çiçin Medical Oncology

Prof. MD. İrfan Çiçin

Liv Hospital Topkapı
Assoc. Prof. MD.  Ramazan Öcal Hematology

Assoc. Prof. MD. Ramazan Öcal

Liv Hospital Ankara
Assoc. Prof. MD. Nazlı Topfedaisi Özkan Gynecological Oncology

Assoc. Prof. MD. Nazlı Topfedaisi Özkan

Liv Hospital Ankara
Prof. MD. Fikret Arpacı Medical Oncology

Prof. MD. Fikret Arpacı

Liv Hospital Ankara
Prof. MD. Gökhan Erdem Medical Oncology

Prof. MD. Gökhan Erdem

Liv Hospital Ankara
Prof. MD. Meral Beksaç Hematology

Prof. MD. Meral Beksaç

Liv Hospital Ankara
Prof. MD. Oral Nevruz Hematology

Prof. MD. Oral Nevruz

Liv Hospital Ankara
Prof. MD. Saadettin Kılıçkap Medical Oncology

Prof. MD. Saadettin Kılıçkap

Liv Hospital Ankara
Prof. MD. Sadık Muallaoğlu Medical Oncology

Prof. MD. Sadık Muallaoğlu

Liv Hospital Ankara
Spec. MD. Ender Kalacı Medical Oncology

Spec. MD. Ender Kalacı

Liv Hospital Ankara
Assoc. Prof. MD. Fadime Ersoy Dursun Hematology

Assoc. Prof. MD. Fadime Ersoy Dursun

Liv Hospital Gaziantep
Prof. MD. Fatih Teker Medical Oncology

Prof. MD. Fatih Teker

Liv Hospital Gaziantep
Spec. MD. ELXAN MEMMEDOV Medical Oncology

Spec. MD. ELXAN MEMMEDOV

Liv Bona Dea Hospital Bakü
Spec. MD. Ceyda Aslan Hematology

Spec. MD. Ceyda Aslan

Spec. MD. Elkhan Mammadov Medical Oncology

Spec. MD. Elkhan Mammadov

Spec. MD. Elmir İsrafilov Hematology

Spec. MD. Elmir İsrafilov

Spec. MD. Minure Abışova Eliyeva Hematology

Spec. MD. Minure Abışova Eliyeva

Spec. MD. Natavan Azizova Medical Oncology

Spec. MD. Natavan Azizova

Need Help? Chat with our medical team

Let's Talk on WhatsApp

📌

Get instant answers from our medical team. No forms, no waiting — just tap below to start chatting now.

or call us at +90 530 510 67 91